Following billionaire investors isn't as difficult as you might imagine thanks to quarterly reporting required by the ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

Novo Nordisk has ... is directed at the application of artificial intelligence and transcriptomic data from humans to the hunt for new medicines for MASH, a form of non-alcoholic steatohepatitis ...

A blockbuster drug is a therapy that generates at least $1 billion in sales. Clarivate’s Drugs to Watch 2025 report includes ...

INR:8839. canadian casino sites Novo Nordisk insulin injection label expansion approved by FDA TCR therapy has been recognized as a breakthrough therapy by ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

The US Food and Drug Administration has rejected a drug approval application from Zealand ... even though Eli Lilly and Novo Nordisk have a head start. The FDA’s rejection of glepaglutide ...

The pump-based platform will be a hybrid closed-loop device that will combine an insulin pump, CGM and a dedicated handheld controller or smartphone application ... like Novo Nordisk and Sanofi ...

A look at news events in June 2024. 1 - Israel's government says its conditions for ending the war with Hamas have not ...

and a marketing authorisation application (MAA) to the European Union in Q1 2025. There have been several developments in ...